(Q37063969)

18 August 2017

1 reference

title

Antisense antivirals (English)

1 reference

18 August 2017

Antisense Antivirals (English)

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

2 December 2022

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

2 December 2022

author name string

J. Goodchild

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1821657

2 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1821657

2 December 2022

publication date

1 January 1991

1 reference

full work available at URL

18 August 2017

http://www.liebertpub.com/doi/pdf/10.1089/ard.1991.1.361

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Antisense research and development

2 December 2022

published in

1 reference

18 August 2017

1

1 reference

18 August 2017

4

1 reference

18 August 2017

361-364

1 reference

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus

18 August 2017

1

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues

2 December 2022

2

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties

2 December 2022

3

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Ribozymes that cleave an RNA sequence from human immunodeficiency virus: the effect of flanking sequence on rate

2 December 2022

4

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides

2 December 2022

5

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Inhibition of rabbit beta-globin synthesis by complementary oligonucleotides: identification of mRNA sites sensitive to inhibition

2 December 2022

6

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

The Clearance and Degradation of Oligodeoxynucleotides Following Intravenous Injection into Rabbits

2 December 2022

7

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Simple RNA enzymes with new and highly specific endoribonuclease activities

2 December 2022

8

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

2 December 2022

9

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

2 December 2022

10

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates

2 December 2022

11

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Ribozymes as potential anti-HIV-1 therapeutic agents.

2 December 2022

12

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

A small catalytic oligoribonucleotide

2 December 2022

13

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

2 December 2022

14

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

2 December 2022

15

1 reference

https://api.crossref.org/works/10.1089/ARD.1991.1.361

2 December 2022

Identifiers

0 references

1 reference